Midwest Cancer Alliance Partners with AONN+ to Advance Oncology Navigation

March 2018 Vol 9, No 3


In the News

The Midwest Cancer Alliance (MCA), the outreach network of The University of Kansas Cancer Center (KUCC), has partnered with the Academy of Oncology Nurse & Patient Navigators (AONN+) to enhance the skills of MCA-member oncology nurse navigators. The KUCC is the only National Cancer Institute–designated cancer center in Kansas, and the MCA links member hospitals, medical professionals, and their patients with KUCC research and services. The MCA network includes more than 60 patient and nurse navigators across the Midwest (Figure).


The AONN+ and MCA will offer membership in the academy to clinical nurse and patient navigators in the MCA system as well as oncology nurse navigator certification as part of the MCA’s ongoing commitment to providing navigation services within their institutions and in rural communities. The AONN+ and MCA will collaborate on developing navigation education and resources for MCA navigators.

Executives from both organizations expressed their enthusiasm for the new partnership. “We are delighted to have the navigators from the Midwest Cancer Alliance join us,” said Lillie D. Shockney, RN, BS, MAS, ONN-CG, Co-Founder and Program Director, AONN+. And MCA Executive Director, Hope Krebill, MSW, BSN, RN, said, “Our partnership with AONN is a great addition to the tools and resources Midwest Cancer Alliance offers our medical colleagues.”

“The growth of navigation as a profession is exciting and gratifying. To bring yet another institution on board is further evidence that navigation tactics help institutions reach their goals of providing value-based, effective patient care,” said AONN+’s Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer and Senior Director of Strategic Planning and Initiatives.

Related Articles
February 8, 2019 - FDA Approvals, News & Updates
News and Updates
  • FDA Approves First Therapy for the Treatment of Adult Patients with a Rare Blood Clotting Disorder
  • FDA Issues Letter to Healthcare Providers Alerting Them to a Risk for Breast Implant Associated–Anaplastic Large-Cell Lymphoma
February 1, 2019 - FDA Approvals, News & Updates
News and Updates
  • FDA Resumes Operations After Government Shutdown Ends
  • FDA Approves New Drug Indication for Use in Hepatocellular Carcinoma
  • FDA Approves Pembrolizumab for Merkel-Cell Carcinoma
Government Shutdown Impacts FDA Drug Approvals
News and Updates
Now in its fourth week, the longest shutdown in the history of the federal government is having an impact on patient care, as the US Food and Drug Administration (FDA) has put drug reviews and approvals for new drugs and devices, as well as the issuance of new guidance documents, on indefinite hold.
Last modified: June 8, 2018

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
  • Please enter your mailing address.

    Address Line 2
    Zip Code